IndiaMTF — home
Stock

SUNPHARMA

Sun Pharmaceutical Industries Limited
Health Technology

Daily Margin Trading Facility book for SUNPHARMA across NSE and BSE, from 03 Jan 2025. All figures in ₹ crore, derived from exchange public disclosures.

Funded value
₹280 Cr
as of 10 Sep 2026
Rank in book
#123
405 days tracked
Share of book
0.18%
of the whole NSE + BSE book
Peak funded
₹281 Cr
on 07 Sep 2026
Largest single-day addition
+₹108 Cr
on 26 May 2026
Largest single-day unwind
−₹90 Cr
on 10 Mar 2026

NSE & BSE split

How SUNPHARMA’s funded book divides across the two exchanges, as of 10 Sep 2026.
NSE
NSE ₹275 Cr · 98.3%BSE ₹5 Cr · 1.7%

MTF vs Price

Margin-funded outstanding for SUNPHARMA in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹1,840.00
as of 11 Sep 2026
Price, 30 days
−7.6%
adjusted for splits and bonuses
Delivery, 20-day avg
64.3%
of traded volume actually settled
Sessions to unwind
1.6
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1 day−₹1−0.3%−0.2%
−3,658
−0.2%unwinding as it falls
10 days+₹6+2.2%+2.1%
+31,800
−2.7%building as it falls
30 days+₹63+29.0%+27.2%
+3,23,679
−7.0%building as it falls
90 days+₹12+4.4%+2.5%
+36,398
+2.9%building into strength
180 days+₹112+67.0%+53.6%
+5,27,230
+3.0%building into strength
1 year+₹193+221.1%+168.9%
+9,49,381
+14.0%building into strength
Price is as of 11 Sep 2026; the MTF book is as of 10 Sep 2026. Exchanges publish the margin file a day after the market data, and the comparison above uses the MTF date for both sides.

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where SUNPHARMA has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

SUNPHARMA — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
10 Sep 2026280−₹10.18%123
09 Sep 2026280+₹10.18%120
08 Sep 2026280−₹10.18%121
07 Sep 2026281+₹50.18%121
04 Sep 2026276+₹20.18%125
03 Sep 2026275+₹30.18%126
02 Sep 2026271+₹20.18%129
01 Sep 2026270+₹150.18%127
31 Aug 2026255−₹140.17%137
28 Aug 2026269−₹50.18%128
27 Aug 2026274+₹00.18%122
26 Aug 2026274+₹10.18%124
25 Aug 2026273−₹20.18%122
24 Aug 2026275−₹40.18%121
21 Aug 2026278−₹10.19%119
20 Aug 2026279+₹20.19%118
19 Aug 2026277−₹20.19%121
18 Aug 2026279+₹20.19%117
17 Aug 2026277+₹160.19%118
14 Aug 2026261+₹20.18%129
13 Aug 2026258+₹00.17%127
12 Aug 2026258−₹00.18%129
11 Aug 2026259+₹10.18%130
10 Aug 2026258−₹20.18%131
07 Aug 2026259+₹90.18%130
06 Aug 2026250−₹60.17%131
05 Aug 2026256+₹100.18%129
04 Aug 2026246+₹10.17%132
03 Aug 2026245+₹190.17%132
31 Jul 2026226—0.16%141

SUNPHARMA within Health Technology

Ranked #5 of 61 funded Health Technology stocks, carrying 4.4% of that sector’s margin book. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector
3WOCKPHARMA
Wockhardt Ltd
₹3836.0%
4ANURAS
Anupam Rasayan India Ltd
₹3816.0%
5SUNPHARMA
Sun Pharmaceutical Industries Limited
₹2804.4%
6DIVISLAB
Divi's Laboratories Limited
₹2664.2%
7GLAND
Gland Pharma Limited
₹2023.2%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.